Skip to main content

Who is John Catanzaro

John Catanzaro, Founder and Chief Science Officer of Neo7Bioscience
Who is John Catanzaro

Click to play

John Catanzaro is the founder and Chief Science Officer of Neo7Bioscience, where he merges oncology, engineering, and systems biology to create personalized peptide therapeutics. His pioneering approach uses genomic mapping and molecular reprogramming to restore homeostasis and reverse chronic disease at the genetic level. With a deep background in immunology and peptide pharmacology, John’s mission is to make precision peptide medicine accessible and clinically transformative. His work is reshaping the future of anti-aging, cancer care, and chronic disease management through biologically intelligent, custom-built therapeutics.

Related Interviews